Change 5-day change 1-year change 3-year change Capi.($)
+0.16%+1.58% - - 52.02M
-2.54%-3.60%-0.60%+15.17% 50.35B
-0.40%+1.03%+439.20%+523.39% 45.2B
-1.42%+2.30%+45.46%+21.22% 44.71B
-1.22%-2.31%+12.40%+74.90% 41.24B
+0.53%-1.67%+15.16%+49.88% 33.08B
-0.21%+9.14% - - 17.81B
-0.35%-1.56%+22.59%+123.04% 16.56B
-1.01%-0.38%+15.69%+28.39% 14.82B
-1.65%-1.03%+77.75%+41.22% 14B
Average -1.02%+0.01%+78.46%+109.65% 30.86B
Weighted average by Cap. -1.38%-0.46%+94.49%+127.49%
Logo Genkyotex SA.
GenKyoTex SA is a France-based company involved in the biotechnology sector. The Company focuses on the development of therapies based on selective inhibition of nicotinamide adenine dinucleotide phosphate oxidase (NOX) enzymes, which cause a range of disease processes, such as fibrosis, inflammation, pain processing, cancer development and neurodegeneration. The Company's pipeline includes GKT831, a NOX inhibitor aimed at primary biliary cholangitis (PBC) and fibrosis; GKT771, a NOX inhibitor mainly aimed at inflammatory pain and angiogenesis, and other NOX inhibitors, which target at central nervous system (CNS), hearing loss and oncology.
Employees
9
  1. Stock Market
  2. Stocks
  3. GKTX Stock